No Data
No Data
Dongyangguang Changjiang Pharmaceutical (01558.HK) plans to pay a special dividend of HK$1.5 per share
Dongyangguang Changjiang Pharmaceutical (01558.HK) announced that it intends to pay a special dividend of HK$1.5 per share.
Guangdong Dongyangguang Pharmaceutical plans to absorb and merge Dongyangguang Changjiang Pharmaceutical (01558) to resume trading on May 13
Dongyangguang Changjiang Pharmaceutical (01558) announced that the company's shares will be at 9:00 a.m. on May 13, 2024...
Dongyangguang Changjiang Pharmaceutical (01558.HK) was absorbed by Guangdong Dongyangyang Pharmaceutical at a premium of about 71.71% and resumed trading on the 13th
Gelonghui, May 10, 丨 Dongyangguang Changjiang Pharmaceutical (01558.HK) announced that on May 10, 2024, the offender Guangdong Dongyangyang Pharmaceutical Co., Ltd. has entered into a merger agreement with the company. According to this, the offeror and the company have agreed to implement the merger in accordance with the terms and conditions of the merger agreement. After the prerequisites and such conditions are met and the share exchange is completed, the company will be delisted. The offeror's H shares will be listed on the main board of the Stock Exchange by means of an introduction, and the company will be merged and absorbed by the offeror in accordance with the terms of the merger agreement, Chinese company law and other applicable Chinese laws. Shareholders in exchange will be entitled to receive from the offeror:
Express News | ST Sunshine: The controlling shareholder received the “Advance Notice of Administrative Penalties” from the China Securities Regulatory Commission
Dongyangguang Changjiang Pharmaceutical (01558): Potential Offerers Are Still Exploring Possible Merger Plans
Dongyangguang Changjiang Pharmaceutical (01558) and potential offender Guangdong Dongyangguang Pharmaceutical Co., Ltd. jointly announced that it is likely to...
Dongyangguang Changjiang Pharmaceutical (01558.HK): Proposed election of the fourth board of directors and supervisors of the Supervisory Board
Dongyangguang Changjiang Pharmaceutical (01558.HK) issued an announcement that the term of the third board of directors is about to expire. On May 6, 2024, the company held a board meeting to consider and approve the following candidates for directors of the fourth board of directors of the company. It can only be confirmed after approval by the company's shareholders at the upcoming 2023 annual general meeting of shareholders of the company:
No Data